Amine Zorgani explains how SwipeBiome moves beyond traditional stool testing toward real-time microbiome prediction based on patient metadata.
Targeting specific bacterial strains, rather than overall gut diversity, can help develop effective microbiota therapies.
In periodontitis, helpful gum bacteria become less active while harmful bacteria change their behavior to feed on available nutrients and worsen disease, suggesting new targeted treatment approaches.
Liam O’Mahony explores how diet influences the immune system through the metabolic activity of the gut microbiota.
Bacterial extracellular vesicles released by L. salivarius activate immune cells, boosting the effectiveness of immunotherapy in stomach cancer.
Uncultured gut bacteria, particularly one group called CAG-170, are key contributors to a healthy microbiota.
Industry, Dermatology
Sponsored by
Building the future with advanced biotechnology.
Giulia Collattuzzo, University of Bologna, presents study findings showing an independent protective association between dietary fiber and gastric cancer risk, with consistent effects across sex, tumor location, and histological subtype.
Why Formula 1 will build the future of personalised medicine before medicine does.
The report by MicrobiomePost distills key trends from Vitafoods Europe 2026.
